1-O-[(5beta,8alpha,9beta,10alpha,13alpha)-13-{[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose

Basic Information

View in Editor

CAS Number

64432-06-0

Molecular Formula

C38H60O17

Molecular Weight

788.88 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Esters

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Surfactants Anionic Surfactants

Polymers and Plastics Thermoplastics Polyolefins

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

Powder

Melting Point

193-195°C

Solubility

N/A

SMILES

View in Editor

C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@@]34CC[C@H]5[C@@]6(CCC[C@@]([C@H]6CC[C@]5(C3)CC4=C)(C)C(=O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)CO)O)O)O)O)O

InChI

InChI=1S/C38H60O17/c1-16-12-37-10-6-20-35(3,8-5-9-36(20,4)34(49)54-32-29(48)26(45)23(42)18(13-39)51-32)21(37)7-11-38(16,15-37)55-33-30(27(46)24(43)19(14-40)52-33)53-31-28(47)25(44)22(41)17(2)50-31/h17-33,39-48H,1,5-15H2,2-4H3/t17-,18+,19+,20-,21-,22-,23+,24+,25+,26-,27-,28+,29+,30+,31-,32-,33-,35+,36+,37+,38-/m0/s1

InChIKey

CANAPGLEBDTCAF-NTIPNFSCSA-N

LogP

-1.910499999999995

Topological Polar Surface Area

274.74999999999994 Å²

Hydrogen Bond Donor/Acceptor

10 / 17

Complexity

1430

Safety Information

View Safety Information

Storage Conditions

2-8℃

Synonyms & References

English

Kaur-16-en-18-oic acid,13-[[2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-, b-D-glucopyranosyl ester, (4a)-
DulcosideA
DULCOSIDE A(P)
DULCOSIDE A(P) PrintBack
Kaur-16-en-18-oic acid,13-[[2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-, b-D-glu...
UNII-BV1X94PJ0P
Dulcoside A
[(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5S,6
[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] 13-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydrox

FAQ

What regulatory guidelines apply to 1-O-[(5beta,8alpha,9beta,10alpha,13alpha)-13-{[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose (CAS: 64432-06-0)?

1-O-[(5beta,8alpha,9beta,10alpha,13alpha)-13-{[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose (CAS: 64432-06-0) requires adherence to GHS classification, REACH regulations, FDA and EPA guidelines for safe handling and disposal. These regulations include proper storage, transportation, and reporting of incidents involving this compound.

Are there alternatives to 1-O-[(5beta,8alpha,9beta,10alpha,13alpha)-13-{[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose (CAS: 64432-06-0) in synthesis?

In the synthesis of 1-O-[(5beta,8alpha,9beta,10alpha,13alpha)-13-{[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose (CAS: 64432-06-0), alternative reagents such as glucose derivatives or other glycosyl donors can be considered. These alternatives may offer similar functionalities but may have different synthetic pathways and reactivity profiles.

What is the market or research trend for 1-O-[(5beta,8alpha,9beta,10alpha,13alpha)-13-{[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose (CAS: 64432-06-0)?

The market for 1-O-[(5beta,8alpha,9beta,10alpha,13alpha)-13-{[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose (CAS: 64432-06-0) is driven by its applications in pharmaceuticals and natural products research. Recent research trends indicate an increasing demand for compounds with specific biological activities, making this compound a focal point in the development of new drugs and natural products.

How should waste containing 1-O-[(5beta,8alpha,9beta,10alpha,13alpha)-13-{[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose (CAS: 64432-06-0) be handled?

Waste containing 1-O-[(5beta,8alpha,9beta,10alpha,13alpha)-13-{[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose (CAS: 64432-06-0) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is a common method for disposal, and strict adherence to environmental protection regulations and guidelines is essential to ensure the safe and sustainable management of this waste.